Glycan’s in Vaccine Development

Glycan’s are at the centre of many disorders and diseases igniting the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycan’s are intricately involved. Determining the entire capacity and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.


    Related Conference of Glycan’s in Vaccine Development

    February 22-23, 2023

    International Bio Summit and Expo

    London, UK
    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    June 27-28, 2023

    3rd Annual Summit on Advanced Bionics

    Vienna, Austria
    September 21-22, 2023

    19th World Congress on Structural Biology

    Paris, France
    September 21-22, 2023

    14th International Conference on Biofuels and Bioenergy

    Toronto, Canada
    October 23-24, 2023

    27th European Biotechnology Congress

    Rome, Italy
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy

    Glycan’s in Vaccine Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in